We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+2.85%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$701M
AUM Growth
+$66.8M
(+11%)
Cap. Flow
+$49.7M
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
47.13%
Holding
388
New
53
Increased
160
Reduced
59
Closed
14
Avg Time Held
2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.1M |
| 2 |
Becton Dickinson
BDX
|
+$3.12M |
| 3 |
Oracle
ORCL
|
+$2.96M |
| 4 |
Travelers Companies
TRV
|
+$2.96M |
| 5 |
Abbott
ABT
|
+$2.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Properties
BXP
|
+$2.49M |
| 2 |
CVS Health
CVS
|
+$2.42M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$969K |
| 4 |
General Mills
GIS
|
+$938K |
| 5 |
Simon Property Group
SPG
|
+$842K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.05% |
| 2 | Technology | 5% |
| 3 | Financials | 4.98% |
| 4 | Healthcare | 4.2% |
| 5 | Industrials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
iShares Core S&P US Growth ETF
IUSG
$33.5B
| $183K | 0.03% |
3,790
| – | – |
2016 Q4
2 quarters
|
|
202
Goldman Sachs
GS
$258B
| $181K | 0.03% |
816
+34
| +4% | +$7.55K |
2013 Q2
16 quarters
|
|
203
Monro
MNRO
$444M
| $178K | 0.03% |
4,255
+665
| +19% | +$33.1K |
2016 Q2
4 quarters
|
|
204
iShares Core S&P US Value ETF
IUSV
$27.9B
| $173K | 0.02% |
3,396
| – | – |
2016 Q4
2 quarters
|
|
205
Bio-Rad Laboratories Class A
BIO
$9.52B
| $170K | 0.02% |
+751
| New | +$164K |
2017 Q2
0 quarters
|
|
206
Novartis
NVS
$287B
| $165K | 0.02% |
2,202
| – | – |
2014 Q4
10 quarters
|
|
207
Universal Health Realty Income Trust
UHT
$530M
| $159K | 0.02% |
+2,000
| New | +$144K |
2017 Q2
0 quarters
|
|
208
iShares US Real Estate ETF
IYR
$4.17B
| $151K | 0.02% |
1,890
| – | – |
2013 Q2
16 quarters
|
|
209
DuPont de Nemours
DD
$17.7B
| $151K | 0.02% |
943
| – | – |
2013 Q4
14 quarters
|
|
210
Union Pacific
UNP
$171B
| $147K | 0.02% |
1,348
| – | – |
2013 Q2
16 quarters
|
|
211
Bristol-Myers Squibb
BMY
$124B
| $142K | 0.02% |
2,553
-3,820
| -60% | -$208K |
2015 Q4
6 quarters
|
|
212
DELISTED
Praxair Inc
PX
| $135K | 0.02% |
1,015
| – | – |
2014 Q1
13 quarters
|
|
213
Aflac
AFL
$59.6B
| $131K | 0.02% |
+3,360
| New | +$126K |
2017 Q2
0 quarters
|
|
214
BP
BP
$129B
| $129K | 0.02% |
+4,207
| New | +$131K |
2017 Q2
0 quarters
|
|
215
Kimberly-Clark
KMB
$34.8B
| $128K | 0.02% |
995
| – | – |
2013 Q4
14 quarters
|
|
216
Western Asset Managed Municipals Fund
MMU
$521M
| $128K | 0.02% |
9,300
| – | – |
2017 Q1
1 quarter
|
|
217
RPM International
RPM
$12.8B
| $128K | 0.02% |
2,340
| – | – |
2014 Q1
13 quarters
|
|
218
Alexandria Real Estate Equities
ARE
$7.14B
| $125K | 0.02% |
+1,038
| New | +$121K |
2017 Q2
0 quarters
|
|
219
Aaon
AAON
$6.18B
| $121K | 0.02% |
+4,913
| New | +$119K |
2017 Q2
0 quarters
|
|
|
ESRX
220
DELISTED
Express Scripts Holding Company
ESRX
| $120K | 0.02% |
1,877
| – | – |
2013 Q2
16 quarters
|
|
221
American Express
AXP
$212B
| $115K | 0.02% |
+1,370
| New | +$108K |
2017 Q2
0 quarters
|
|
222
Alphabet (Google) Class A
GOOGL
$4.19T
| $115K | 0.02% |
2,480
| – | – |
2015 Q4
6 quarters
|
|
|
XLNX
223
DELISTED
Xilinx Inc
XLNX
| $115K | 0.02% |
1,785
| – | – |
2014 Q1
13 quarters
|
|
224
American Airlines Group
AAL
$8.02B
| $112K | 0.02% |
2,230
| – | – |
2016 Q3
3 quarters
|
|
225
Crown Castle
CCI
$34.8B
| $112K | 0.02% |
1,113
+53
| +5% | +$5.21K |
2015 Q1
9 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q2 2017 Portfolio in Review
As of Q2 2017, Capital Analysts LLC held 388 positions worth $701M, up 11% from $634M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Capital Analysts LLC deployed $49.7M of net new capital in Q2 2017, opening 53 new positions and adding to 160 existing holdings. Its largest new stake was Apple: 110,832 shares worth $3.99M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 72% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Boston Properties, an estimated $2.49M trimmed.
- Capital Analysts LLC's largest Q2 2017 buy was Apple: 110,832 shares worth $3.99M.
- Capital Analysts LLC added most to Oracle in Q2 2017, an estimated $2.96M increase.
- Capital Analysts LLC's biggest Q2 2017 reduction was Boston Properties, cutting an estimated $2.49M.
- Capital Analysts LLC fully exited General Mills in Q2 2017, selling an estimated $938K.
- Capital Analysts LLC's ten largest holdings make up 47% of its $701M portfolio in Q2 2017.
- Capital Analysts LLC opened 53 new positions and closed 14 in Q2 2017.
- Capital Analysts LLC's portfolio value rose 11% quarter-over-quarter to $701M.
Based on Capital Analysts LLC's 13F filing for Q2 2017, filed 8 Aug 2017.